Secondary hyperparathyroidism in X-linked hypophosphatemic mice

Area of Science:

• Endocrinology
• Mineral Metabolism
• Animal Models of Human Disease

Background:

• X-linked hypophosphatemia (XLH) is a genetic disorder characterized by impaired phosphate reabsorption and bone mineralization.
• Hyp mice serve as a valuable animal model for studying XLH pathogenesis.
• Parathyroid hormone (PTH) plays a crucial role in calcium and phosphate homeostasis.

Purpose of the Study:

• To investigate plasma parathyroid hormone (PTH) levels in Hyp mice, an animal model for X-linked hypophosphatemia.
• To compare PTH levels between Hyp mice and age-matched normal mice.
• To explore the potential role of hyperparathyroidism in the pathophysiology of Hyp mice.

Main Methods:

• Plasma samples were collected from adult, age-matched, intact normal mice and Hyp male mice.
• Parathyroid hormone (PTH) levels were measured using a radioimmunoassay (RIA) capable of detecting intact and carboxyl-terminal fragments.
• Statistical analysis was performed to compare PTH levels between the two groups.

Main Results:

• Hyp mice exhibited significantly higher plasma PTH levels (0.21 +/- 0.03 ng bovine PTH eq/ml) compared to normal mice (0.04 +/- 0.03 ng/ml; P < 0.01).
• The observed hyperparathyroidism in Hyp mice occurred alongside mild hypocalcemia and osteomalacia.
• Elevated PTH in Hyp mice may be linked to skeletal resistance to its effects.

Conclusions:

• Hyp mice demonstrate elevated plasma PTH levels, indicating secondary hyperparathyroidism.
• This hyperparathyroidism may result from skeletal resistance to endogenous PTH in the context of X-linked hypophosphatemia.
• The findings suggest that hyperparathyroidism contributes to the characteristic renal phosphate wasting and elevated urinary cAMP observed in Hyp mice.